D. Schwope

Characterization of drug-drug interactions in patients whose substance intake was objectively identified by detection in urine

J. Schrecker, B. Puet, Cheryl Hild, 2018, Expert opinion on drug metabolism & toxicology.

Cannabinoid disposition in oral fluid after controlled smoked cannabis.

M. Huestis, D. Gorelick, Allan J Barnes, 2012, Clinical chemistry.

Validation of an enzyme immunoassay for detection and semiquantification of cannabinoids in oral fluid.

M. Huestis, D. Schwope, G. Milman, 2010, Clinical chemistry.

In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis.

Nathalie A. Desrosiers, M. Huestis, D. Gorelick, 2013, Clinical chemistry.

Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration.

M. Huestis, D. Gorelick, D. Schwope, 2011, Clinical chemistry.

Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography–tandem mass spectrometry

M. Huestis, K. Scheidweiler, D. Schwope, 2011, Analytical and bioanalytical chemistry.

Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC.

D. Kelly, M. Huestis, D. Gorelick, 2009, Clinical chemistry.